who invented semaglutide History of glucagon-like peptide-1 receptor agonists The Discovery and Development of

Background In idiopathic intracranial hypertension (IIH), sustained weight loss is the main pillar in modifying disease course, whereby glucagon-like peptide-1 receptor agonists (GLP-1-RAs) could present an attractive treatment option

A dual ANCC board-certified NP walks through what to do when insurance denies a GLP-1 medication: how to read the denial, what documentation helps, and when to appeal.

Background Idiopathic intracranial hypertension (IIH) is a debilitating neurologic condition marked by elevated intracranial pressure (ICP), typically affecting obese women of reproductive age

Whether you're taking Ozempic, Wegovy, Mounjaro, or another GLP-1 medication

I've been wearing them continuously for about 3 weeks now, and my body has slowly undergone positive changes, almost like the stored fat in my abdomen is gradually disappearing, making my stomach slimmer